Topic: Policy: Fair Access

Fair Access: Coverage Policies in 2022

Jan 2023 | Policy Paper

While many key elements of fair access were not able to be assessed, the analysis found that major payer coverage policies for 19 drugs demonstrated high concordance with many fair access criteria related to cost sharing, clinical eligibility, step therapy, and provider restrictions.  During ICER’s assessment, five payers revised policies for 11 drugs in ways […]

Fair Access: Coverage Policies in 2020

Dec 2021 | Policy Paper

In September 2020, ICER published the white paper: “Cornerstones of ‘Fair’ Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals.” This paper analyzes the ethical and practical dimensions of insurance coverage policy, while presenting a corresponding set of criteria that will support a more transparent discussion among all health care stakeholders about whether specific […]

Cornerstones of ‘Fair’ Drug Coverage

Sep 2020 | Policy Paper

The purpose of the white paper is to analyze the ethical and practical dimensions of insurance coverage policy, while presenting a corresponding set of criteria that will support a more transparent discussion among all health care stakeholders about whether specific cost sharing and utilization management policies are delivering “fair” patient access to prescription drugs. Date […]